Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
65.87B | 43.03B | 94.64B | 107.81B | 87.19B | Gross Profit |
65.87B | 138.16B | 94.64B | 107.81B | 87.19B | EBIT |
0.00 | 40.20B | 12.90B | 12.17B | 8.91B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
11.69B | 10.97B | 9.85B | 9.49B | 7.07B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
308.05B | 408.22B | 330.49B | 358.04B | 317.08B | Total Assets |
2.70T | 2.59T | 2.67T | 2.63T | 2.49T | Total Debt |
0.00 | 673.44B | 625.71B | 718.22B | 687.29B | Net Debt |
-308.05B | -408.22B | 151.66B | 233.95B | 274.71B | Total Liabilities |
2.57T | 2.46T | 2.55T | 2.52T | 2.38T | Stockholders Equity |
128.14B | 123.74B | 109.99B | 108.68B | 102.85B |
Cash Flow | Free Cash Flow | |||
-99.51B | -36.46B | 21.28B | 26.18B | 4.43B | Operating Cash Flow |
-97.38B | -34.24B | 23.81B | 27.84B | 5.21B | Investing Cash Flow |
-180.00M | 7.30B | -78.81B | 13.35B | 133.27B | Financing Cash Flow |
-6.42B | -4.68B | 9.25B | 14.52B | 18.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $61.47B | 11.30 | 11.15% | 3.98% | 3.46% | 19.01% | |
77 Outperform | $120.50B | 19.95 | 17.89% | 0.59% | 22.15% | 12.13% | |
76 Outperform | $84.41B | 7.39 | 9.69% | 4.40% | 5.70% | 11.52% | |
76 Outperform | $63.55B | 8.76 | 20.84% | 5.60% | -7.01% | 15.18% | |
76 Outperform | $56.17B | 11.67 | 9.95% | 4.20% | 36.29% | -19.79% | |
65 Neutral | $59.51B | 10.64 | 8.56% | 2.36% | 13.63% | 27.77% | |
64 Neutral | $12.64B | 9.74 | 8.05% | 17044.60% | 12.66% | -4.62% |